The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LDLR is a receptor that binds to apolipoprotein B and apoE in the periphery to facilitate the uptake of cholesterol-laden lipoproteins by cells [38].”
From Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling (2012) · cites this paper as [38]
In the citing paper
“Ldlr is normally localized to the plasma membrane where it binds extracellular ApoE lipoproteins followed by endocytosis and subsequent release of bound lipids in the lysosome (62).”
From Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol (2023) · cites this paper as [62]
In the citing paper
“LDLR is a cell surface glycoprotein that plays an important role in mediating the removal of cholesterol and cholesteryl ester-containing low-density lipoprotein (LDL) particles from the circulation (Brown and Goldstein, 1986; Herz and Bock, 2002).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“LDL is catabolized by the liver via the LDL receptor (LDLR), which binds APOB and removes LDL from circulation and traffics it to the endosomal system for degradation (15).”
From Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism (2012) · cites this paper as [15]
In the citing paper
“internalized LDL is released from LDLR in acidic compartments (29, 30)”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [30]
In the citing paper
“Cholesterol derived from low-density lipoprotein (LDL) is taken into cells through endocytosis mediated by LDL receptors (LDLRs) (1).”
From Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine (2020) · cites this paper as [1]
In the citing paper
“LDL-derived cholesterol is taken up by LDLRs and released in lysosomes (1).”
From Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine (2020) · cites this paper as [1]
In the citing paper
“A number of scholars reported that LDLR is a major determinant of circulating levels of LDL.[16][17][18]”
From USP16 Regulates the Stability and Function of LDL receptor by Deubiquitination (2020) · cites this paper as [18]
In the citing paper
“Upon binding of plasma LDLs, cell surface LDLRs are internalized and transported to endosomes, where low pH causes LDLR-LDL dissociation1.”
From Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation (2020) · cites this paper as [1]
In the citing paper
“As a transmembrane glycoprotein, low-density lipoprotein receptor (LDLR) is abundantly expressed on the surface of hepatocytes, where it facilitates the uptake of LDL cholesterol and maintains the homeostasis of lipid metabolism20,21.”
From ABCC4 impairs the clearance of plasma LDL cholesterol through suppressing LDLR expression in the liver (2025) · cites this paper as [21]
In the citing paper
“Low expression level of low-density lipoprotein receptor (LDLR) in hepatocytes leads to hypercholesterolemia and eventually contributes to atherosclerotic cardiovascular disease (ASCVD).”
From ABCC4 impairs the clearance of plasma LDL cholesterol through suppressing LDLR expression in the liver (2025) · cites this paper as [21]
In the citing paper
“Complete absence or defective LDLRs due to mutations in the LDLR gene cause FH, characterized by an autosomal dominant inheritance of hypercholesterolemia and premature ASCVD (a list of mutations can be found in Table 1)1–4.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [2]
In the citing paper
“where it is concentrated into clathrin-coated pits to internalize bound LDL by receptor-mediated endocytosis (discussed separately below)2”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [2]
In the citing paper
“Low-density lipoprotein receptor (LDLR) is an integral membrane protein that is most abundantly expressed in the liver, where it binds to and removes LDL-C from the circulation by endocytosis4,5.”
From Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA (2018) · cites this paper as [4]
In the citing paper
“Feedback suppression of SREBP2 pathway by LDLR plays a pivotal role in maintaining the balance of cholesterol levels between liver and blood (Brown and Goldstein, 1986).”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“hepatic cells also play major roles in removing LDL from the circulation”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The main carriers of atherogenic circulating cholesterol in humans are the LDL particles, which are produced mainly by the liver to deliver cholesterol to peripheral tissues”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The balance of serum cholesterol level is determined by dietary intake, synthesis, and catabolism”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“LDL clearance from the circulation by LDL receptor (LDLR)-mediated endocytosis by hepatic and peripheral tissues and subsequent feedback regulation of endogenous synthesis of cholesterol is a key determinant of serum LDL level”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“Excessive cholesterol in the circulation, upon uptake by the liver via LDL receptor (LDLR)-mediated endocytosis, suppresses endogenous synthesis of cholesterol in the liver”
From Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol (2016) · cites this paper as [7]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [2]
In the citing paper
“Following dissociation of the LDLR-LDL complex, LDL is directed to lysosomes whereas the LDLR recycles to the plasma membrane.”
From The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation (2013) · cites this paper as [2]
In the citing paper
“Low density lipoprotein (LDL) cholesterol is taken up into cells via clathrin-mediated endocytosis of the LDL receptor (LDLR).”
From The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation (2013) · cites this paper as [2]
In the citing paper
“LDL, which is derived by peripheral lipolysis of VLDL (very-low-density lipoprotein), is primarily cleared from the circulation in the liver via the LDLR (LDL receptor) pathway.1,2”
From (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis (2018) · cites this paper as [1]
In the citing paper
“This results in induction of the full set of genes required for de novo biosynthesis of cholesterol via the mevalonate pathway and of the low-density lipoprotein receptor (LDLR) that is required for uptake of LDL-derived cholesterol (7,8).”
From A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes (2016) · cites this paper as [8]
In the citing paper
“The LDLR structure from the N-terminus to the C-terminus includes seven ligand-binding domain repeats, an epidermal growth factor (EGF) precursor homology domain, an O-linked sugar domain, a transmembrane domain, and a cytoplasmic domain”
From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Brown and Goldstein, 1986
In the citing paper
“Early studies on normal and FH fibroblasts demonstrated that LDLRs, shortly after being synthesized, appear on the cell surface where they gather in coated pits (1).”
In the citing paper
“The low density lipoprotein receptor (LDLR) 2 plays a pivotal role in the regulation of cholesterol metabolism (1).”
In the citing paper
“As noted in the Introduction, LDLR tends to cluster in clathrincoated pits on the cell surface under defined conditions.”
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Carbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,815
Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630
Flagged first, then by citations
Research works printed but not linked: 13
- BAILEY, J.M., CIBA FOUNDATION SYMPOSIUM 12: 63 (1973).
- BROWN, M.S., RECENT PROGRESS IN HORMONE RESEARCH 35: 215 (1979).
- Calvert, G. D. F., Low Density Liproteins: 281 (1976).
- FREDRICKSON, D.S., HARVEY LECTURE SERIES 68: 185 (1974).
- Fredrickson, D. S., The Metabolic Basis of Inherited Disease: 545 (1972).
- GOFMAN, J.W., PLASMA 2: 413 (1954).
- GOLDSTEIN, J.L., LIPOPROTEIN RECEPTORS - GENETIC DEFENSE AGAINST ATHEROSCLEROSIS, CLINICAL RESEARCH 30: 417 (1982).
- KOVANEN, P.T., INCREASED BINDING OF LOW-DENSITY LIPOPROTEIN TO LIVER MEMBRANES FROM RATS TREATED WITH 17-ALPHA-ETHYNYL ESTRADIOL, JOURNAL OF BIOLOGICAL CHEMISTRY 254: 1367 (1979).
- Lehrman, M. A., Proceedings of the National Academy of Sciences of the United States of America 83: 3679 (1986).
- MULLER, C, ACTA MEDICA SCANDINAVICA 89: 75 (1938).
- ONCLEY, J.L., HARVEY LECTURES 50: 71 (1956).
- PALADE, G. E., JOURNAL OF APPLIED PHYSICS 24: 1424 (1953).
- SCHNEIDER, W.J., MOL BIOL MED 1: 353 (1983).
Cited by
Sorted by citations
Items 301–400 of 1,059
The crystal structure of PCSK9: A regulator of plasma LDL-cholesterol
Piper, D. E., Jackson, S., Liu, Q., Romanow, W. G., Shetterly, S., Thibault, S. T., Shan, B., & Walker, N. P. C. (2007) · Structure · doi:10.1016/j.str.2007.04.004 · Cited by 251
Identification of a Zinc Finger Protein That Binds to the Sterol Regulatory Element
Rajavashisth, T. B., Taylor, A. K., Andalibi, A., Svenson, K. L., & Lusis, A. J. (1989) · Science · doi:10.1126/science.2562787 · Cited by 251
Goldstein, J. L., Rawson, R. B., & Brown, M. S. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2615 · Cited by 214
Self-citationBrown, D., Gluck, S. L., & Hartwig, J. H. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.4.1637 · Cited by 250
Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T. P., & Sahebkar, A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25756 · Cited by 252
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro, R. G. R., Coutinho, A. J., Pinheiro, M., & Neves, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111654 · Cited by 251
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 244
Dietschy, J. M. (1998) · Journal of Nutrition · doi:10.1093/jn/128.2.444s · Cited by 247
Linton, M. F., Farese, R. V., Chiesa, G., Grass, D., Chin, P., Hammer, R. E., Hobbs, H. H., & Young, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116927 · Cited by 246
Liscum, L., & Faust, J. R. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45483-x · Cited by 245
The role of the LDL receptor in apolipoprotein B secretion
Twisk, J., Gillian‐Daniel, D. L., Oler, A. T., Wang, L., Barrett, P. H. R., & Attie, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8623 · Cited by 245
Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
Nikolić, J., Belot, L., Raux, H., Legrand, P., Gaudin, Y., & Albertini, A. (2018) · Nature Communications · doi:10.1038/s41467-018-03432-4 · Cited by 253
Orth, K., Madison, E. L., Gething, M.-J. H., Sambrook, J., & Herz, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7422 · Cited by 243
Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH
Surdo, P. L., Bottomley, M. J., Calzetta, A., Settembre, E. C., Cirillo, A., Pandit, S., Ni, Y. G., Hubbard, B., Sitlani, A., & Carfí, A. (2011) · The EMBO Reports · doi:10.1038/embor.2011.205 · Cited by 226
Targeting tumor cell metabolism with statins
Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 247
Cholesterol metabolism during ketoconazole treatment in man.
Miettinen, T. A. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38566-7 · Cited by 241
Antiartherosclerotic Effects of Plant Flavonoids
Salvamani, S., Gunasekaran, B., Shaharuddin, N. A., Ahmad, S. A., & Shukor, M. Y. (2014) · BioMed Research International · doi:10.1155/2014/480258 · Cited by 240
Targeted delivery of proteins across the blood–brain barrier
Spencer, B. J., & Verma, I. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702170104 · Cited by 249
Apolipoproteins: metabolic role and clinical biochemistry applications
Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238
Evidence for a Niemann–Pick C (NPC) Gene Family: Identification and Characterization of NPC1L1
Davies, J. P., Levy, B., & Ioannou, Y. A. (2000) · Genomics · doi:10.1006/geno.2000.6151 · Cited by 234
Infante, R. E., Abi-Mosleh, L., Radhakrishnan, A., Dale, J. D., Brown, M. S., & Goldstein, J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707943200 · Cited by 242
Self-citationFuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., & Williams, K. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119685 · Cited by 213
Herz, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00234-3 · Cited by 238
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.
Austin, M. A., King, M., VRANIZAN, K. M., Newman, B. M., & Krauss, R. M. (1988) · PubMed · Cited by 234
Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor
Zhang, D.-W., Garuti, R., Tang, W.-J., Cohen, J. C., & Hobbs, H. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806312105 · Cited by 208
Differential lipoprotein transport pathways of K-vitamins in healthy subjects
Schurgers, L. J., & Vermeer, C. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00147-2 · Cited by 234
Weisgraber, K. H., Mahley, R. W., Kowal, R. C., Herz, J., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45726-2 · Cited by 235
Self-citationTHOMSSEN, R., Bonk, S., & Thiele, A. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00191948 · Cited by 234
de la Llera-Moya, M., Rothblat, G. H., Connelly, M. A., Kellner-Weibel, G., Sakr, S. W., Phillips, M. C., & Williams, D. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32462-7 · Cited by 234
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Qian, Y.-W., Schmidt, R. J., Zhang, Y., Chu, S., Lin, A., Wang, H., Wang, X., Beyer, T. P., Bensch, W. R., Li, W., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700071-jlr200 · Cited by 194
Temel, R. E., Trigatti, B. L., Demattos, R. B., Azhar, S., Krieger, M., & Williams, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13600 · Cited by 233
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Tacer, K. F., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 242
Sokol, J., Blanchette‐Mackie, J., Kruth, H. S., Dwyer, N. K., Amende, L. M., Butler, J. D., Robinson, E., Patel, S., Brady, R. O., & Comly, M. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69086-6 · Cited by 232
Lipids, lysosomes, and autophagy
Jaishy, B. P., & Abel, E. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067520 · Cited by 239
Contois, J. H., McNamara, J. R., Lammi‐Keefe, C. J., Wilson, P. W. F., Massov, T., & Schaefer, E. J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.4.515 · Cited by 231
Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.
Chan, L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35646-1 · Cited by 231
Utermann, G., Hoppichler, F., Dieplinger, H., Seed, M., Thompson, G. R., & Boerwinkle, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4171 · Cited by 231
Galeano, N. F., Al-Haideri, M. T., Keyserman, F., Rumsey, S. C., & Deckelbaum, R. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32551-7 · Cited by 229
Biology of Cardiac Arrhythmias
Delisle, B. P., Anson, B. D., Rajamani, S., & January, C. T. (2004) · Circulation Research · doi:10.1161/01.res.0000128561.28701.ea · Cited by 227
Molecular Genetics of Human Retinal Disease
Rattner, A., Sun, H., & Nathans, J. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.89 · Cited by 228
Landlinger, C., Pouwer, M. G., Juno, C., van der Hoorn, J. W. A., Pieterman, E. J., Jukema, J. W., Staffler, G., Princen, H. M. G., & Galabova, G. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx260 · Cited by 240
Interstitial fluid lipoproteins.
Sloop, C. H., Dory, L., & Roheim, P. S. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38701-0 · Cited by 228
The complete cDNA and amino acid sequence of human apolipoprotein B-100.
Chen, S. H., Yang, C. Y., Pei‐Feng, C. H. E. N., Setzer, D. R., Tanimura, M., Li, W., Gotto, A. M., & Chan, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69248-8 · Cited by 228
Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition
Dawson, P. A. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_4 · Cited by 227
Stimulation of Fecal Steroid Excretion After Infusion of Recombinant Proapolipoprotein A-I
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 227
NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes
Pfeffer, S. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.004165 · Cited by 226
Takahashi, S., Suzuki, J., Kohno, M., Oida, K., TAMAI, T., Miyabo, S., Yamamoto, T. T., & NAKAI, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15747 · Cited by 226
Suzuki, S., Argraves, W. S., Pytela, R., Arai, H., Krusius, T., Pierschbacher, M. D., & Ruoslahti, E. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8614 · Cited by 226
Clinical Pharmacokinetics of Pravastatin
Hatanaka, T. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039060-00002 · Cited by 225
Jeon, H., Meng, W., Takagi, J., Eck, M. J., Springer, T. A., & Blacklow, S. C. (2001) · Nature Structural Biology · doi:10.1038/88556 · Cited by 225
Yan, J., Liao, K., Wang, T., Mai, K., Xu, W., & Ai, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129937 · Cited by 224
Laws, S. M., Hone, E., Gandy, S., & Martins, R. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01615.x · Cited by 223
Receptor‐Mediated Endocytosis in the Bloodstream Form of Trypanosoma brucei1
Coppens, I., Opperdoes, F. R., Courtoy, P. J., & Baudhuin, P. (1987) · The Journal of Protozoology · doi:10.1111/j.1550-7408.1987.tb03216.x · Cited by 223
Infante, R. E., Radhakrishnan, A., Abi-Mosleh, L., Kinch, L. N., Wang, M. L., Grishin, N. V., Goldstein, J. L., & Brown, M. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707944200 · Cited by 230
Self-citationHepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Strong, A., Ding, Q., Edmondson, A. C., Millar, J. S., Sachs, K. V., Li, X., Kumaravel, A., Wang, M. Y., Ai, D., Guo, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63563 · Cited by 222
Hazen, S. L., Hsu, F. F., Duffin, K., & Heinecke, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23080 · Cited by 221
Lipoprotein receptors: new roles for ancient proteins
Willnow, T. E., Nykjaer, A., & Herz, J. (1999) · Nature Cell Biology · doi:10.1038/14109 · Cited by 181
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 222
Genetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 219
Christians, U., Jacobsen, W., & Floren, L. C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00016-3 · Cited by 222
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 227
Apolipoprotein E receptors: linking brain development and alzheimer's disease
Herz, J., & Beffert, U. (2000) · Nature reviews. Neuroscience · doi:10.1038/35036221 · Cited by 224
Dubois, C., Beaumier-Gallon, G., Juhel, C., Armand, M., Portugal, H., Pauli, A.-M., Borel, P., Latge, C., & Lairon, D. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.31 · Cited by 218
Current status on development of steroids as anticancer agents
Gupta, A. K., Kumar, B. S., & Negi, A. S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.011 · Cited by 218
Nieland, T. J. F., Penman, M., Dori, L., Krieger, M., & Kirchhausen, T. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222421399 · Cited by 216
Miettinen, T. A., & Kesäniemi, Y. A. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.4.629 · Cited by 216
Regulation of cholesterol homeostasis
Goedeke, L., & Fernandez-Hernando, C. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0857-5 · Cited by 232
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 217
Simonet, W. S., Bucay, N., Lauer, S., & Taylor, J. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53085-4 · Cited by 213
Graham, D. L., & Oram, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47584-9 · Cited by 215
Wang, M. L., Motamed, M., Infante, R. E., Abi-Mosleh, L., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.016 · Cited by 214
Self-citationOxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
Heinecke, J. W., Kawamura, M., Suzuki, L. A., & Chait, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35347-5 · Cited by 214
Structure of apolipoprotein B-100 of human low density lipoproteins.
Yang, C. Y., Gu, Z., Weng, S. A., Kim, T. W., Chen, S. H., Pownall, H. J., Sharp, P. M., Liu, S. W., Li, W., & Gotto, A. M. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.1.96 · Cited by 212
Mammalian acyl-CoA:cholesterol acyltransferases
Buhman, K. K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00144-x · Cited by 214
Ghosh, R. N., Gelman, D. L., & Maxfield, F. R. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.8.2177 · Cited by 176
Cholesterol trafficking is required for mTOR activation in endothelial cells
Xu, J., Dang, Y., Ren, Y. R., & Liu, J. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910872107 · Cited by 209
Lalazar, A., Weisgraber, K. H., Rall, S. C., Giladi, H., Innerarity, T. L., Levanon, A. Z., Boyles, J. K., Amit, B., Gorecki, M., & Mahley, R. W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68957-4 · Cited by 209
Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J. P., Liu, X., Previs, S. F., Willard, B. B., Smith, J. D., & McCullough, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126910 · Cited by 209
Lange, L. A., Hu, Y., Zhang, H., Xue, C., Schmidt, E. M., Tang, Z.-Z., Bizon, C., Lange, E. M., Smith, J. D., Turner, E. H., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.01.010 · Cited by 212
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Bovenga, F., Sabbà, C., & Moschetta, A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.002 · Cited by 209
Role of the steroidogenic acute regulatory protein in health and disease
Manna, P. R., Stetson, C. L., Slominski, A. T., & Pruitt, K. (2015) · Endocrine · doi:10.1007/s12020-015-0715-6 · Cited by 218
Cenedella, R. J. (2009) · Lipids · doi:10.1007/s11745-009-3305-7 · Cited by 209
Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.
Lehtimäki, T. J., Moilanen, T. P. S., Viikari, J. S. A., Akerblom, H., Ehnholm, C., Rönnemaa, T., Marniemi, J., Dahlén, G., & Nikkari, T. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43170-0 · Cited by 205
Lipoprotein Uptake by Neuronal Growth Cones in Vitro
Ignatius, M. J., Shooter, E. M., Pitas, R. E., & Mahley, R. W. (1987) · Science · doi:10.1126/science.3576212 · Cited by 207
Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis
Aviram, M., & Fuhrman, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02913.x · Cited by 204
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Woollett, L. A. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1155 · Cited by 205
Maletı́nská, L., Blakely, E. A., Bjornstad, K. A., Deen, D. F., Knoff, L. J., & Forte, T. M. (2000) · PubMed · Cited by 205
Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima
Pentikäinen, M. O., Öörni, K., Ala‐Korpela, M., & Kovanen, P. T. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00655.x · Cited by 204
Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome
Scopinaro, N., Marinari, G. M., Camerini, G. B., Papadia, F. S., & Adami, G. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2406 · Cited by 204
Niemann–Pick C2 (NPC2) and intracellular cholesterol trafficking
Storch, J., & Xu, Z. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.001 · Cited by 216
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol
Giugliano, R. P., Wiviott, S. D., Blazing, M. A., Ferrari, G. M. D., Park, J., Murphy, S. A., White, J. A., Tershakovec, A. M., Cannon, C. P., & Braunwald, E. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0083 · Cited by 209
Marschall, H., & Einarsson, C. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01783.x · Cited by 211
Yamazaki, H., Bujo, H., Kusunoki, J., Seimiya, K., Kanaki, T., Morisaki, N., Schneider, W. J., & Saitō, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24761 · Cited by 205
Després, J. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80289-7 · Cited by 205
Steinberg, D. H. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600009-jlr200 · Cited by 205
Blanchette‐Mackie, E. J., Dwyer, N. K., Amende, L. M., Kruth, H. S., Butler, J. D., Sokol, J., Comly, M. E., Vanier, M. T., August, J. T., & Brady, R. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8022 · Cited by 201
The Role of Vitamin E and Carotenoids in Preventing Oxidation of Low Density Lipoproteinsa
Esterbauer, H., Striegl, G., Puhl, H., OBERREITHER, S., Rotheneder, M., EL‐SAADANI, M., & Jürgens, G. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb14925.x · Cited by 201
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease
Arnett, D. K., Baird, A. E., Barkley, R. A., Basson, C. T., Boerwinkle, E., Ganesh, S. K., Herrington, D. M., Hong, Y., Jaquish, C. E., McDermott, D. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.183679 · Cited by 205
Genetic heterogeneity of autosomal dominant hypercholesterolemia
Varret, M., Abifadel, M., Rabès, J., & Boileau, C. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00915.x · Cited by 202
Metadata
- Authors
- Brown, M. S., & Goldstein, J. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Science
- Published
- 1986-04-04
- Volume
- 232
- Issue
- 4746
- Pages
- 34-47
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2084744450
- Semantic Scholar
- 272a968782c9511ffde67976c781969ead33e19e
- Cited by
- 5,703
- References
- 151
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 61 · 2023: 105 · 2022: 107 · 2021: 125 · 2020: 118 · 2019: 108 · 2018: 131 · 2017: 140 · 2016: 130 · 2015: 145 · 2014: 139 · 2013: 134 · 2012: 139
- FWCI
- 30.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cholesterol homeostasis, cholesterol metabolism, lipid transport
- MeSH terms
- Biological Transport, Cholesterol, Endocytosis, Homeostasis, Humans, Hyperlipoproteinemia Type II, Kinetics, Lipid Metabolism, Inborn Errors, Lipoproteins, HDL, Lipoproteins, LDL, Models, Biological, Mutation, Receptors, LDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
